Literature DB >> 4302180

Radioimmunoassay of ACTH in plasma.

S A Berson, R S Yalow.   

Abstract

Techniques are described in detail for a radioimmunoassay of plasma adrenocorticotropin (ACTH) that is capable of detecting hormone in unextracted normal human plasma at 1:5 dilution under the conditions described. The sensitivity of the assay is at the level of 1 mumug/ml (equivalent to 0.014 mU/100 ml). In normal subjects ACTH concentrations averaged 22 mumug/ml (equivalent to 0.308 mU/100 ml) plasma at 8-10 a.m. In a smaller group the concentrations averaged 9.6 mumug/ml (equivalent to 0.134 mU/100 ml) at 10-11 p.m. Although a circadian rhythm in normal subjects was not always well marked throughout the daytime hours, plasma ACTH usually fell to its lowest value in the late evening. In hospital patients who were not acutely ill, concentrations were infrequently above 100 mumug/ml in the morning and usually fell to significantly lower levels in the late evening. Severely ill hospital patients occasionally exhibited a.m. concentrations above 200 mumug/ml. In a group of subjects showing frequent spiking of plasma 17-OHCS concentrations throughout the day parallel spiking of plasma ACTH as well was generally observed.Metyrapone produced marked increases in plasma ACTH within 24 hr in all cases and generally within 3-6 hr except when started late in the day. Dexamethasone brought about a persistent reduction in plasma ACTH in a patient under continued treatment with metyrapone.Hypoglycemia, electroshock, surgery under general anesthesia, histalog and vasopressin administration were usually followed by significant increases in plasma ACTH concentration. Prior administration of dexamethasone blocked the response to hypoglycemia. Marked elevations in plasma ACTH were observed in patients with adrenal insufficiency off steroid therapy, in Cushing's disease after adrenalectomy even in the presence of persistent hypercortisolemia, and in some untreated patients with Cushing's disease. Umbilical cord blood contained higher plasma ACTH concentrations than maternal blood at delivery in seven of eight cases. After suppression of ACTH secretion by dexamethasone or cortisol. ACTH disappeared from plasma with half-times ranging from 22 min to 30 min in three cases studied.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4302180      PMCID: PMC297443          DOI: 10.1172/JCI105955

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  RADIOIMMUNOASSAY OF HUMAN PLASMA ACTH.

Authors:  R S YALOW; S M GLICK; J ROTH; S A BERSON
Journal:  J Clin Endocrinol Metab       Date:  1964-11       Impact factor: 5.958

2.  Oxidation-reduction properties of adrenocorticotrophic hormone.

Authors:  M L DEDMAN; T H FARMER; C J MORRIS
Journal:  Biochem J       Date:  1954-12-17       Impact factor: 3.857

3.  Adrenocorticotropic hormone in human plasma.

Authors:  V K VANCE; W J REDDY; D H NELSON; G W THORN
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

4.  ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome.

Authors:  D H NELSON; J W MEAKIN; G W THORN
Journal:  Ann Intern Med       Date:  1960-03       Impact factor: 25.391

5.  Plasma adrenocorticotrophic hormone in Addison's disease and its modification by the administration of adrenal steroids.

Authors:  J E BETHUNE; D H NELSON; G W THORN
Journal:  J Clin Invest       Date:  1957-12       Impact factor: 14.808

6.  The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: an attempt to explain and correct its disordered hormonal pattern.

Authors:  F C BARTTER; F ALBRIGHT; A P FORBES; A LEAF; E DEMPSEY; E CARROLL
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

7.  Functional relationship between the adrenal cortex and posterior pituitary.

Authors:  C S NAGAREDA; R GAUNT
Journal:  Endocrinology       Date:  1951-05       Impact factor: 4.736

8.  Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica.

Authors:  G Rosselin; R Assan; R S Yalow; S A Berson
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

9.  Effects of a bacterial pyrogen on the pituitary-adrenal axis at various times in the 24 hours.

Authors:  K Takebe; C Setaishi; M Hirama; M Yamamoto; Y Horiuchi
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

Review 10.  Labeling of proteins--problems and practices.

Authors:  R S Yalow; S A Berson
Journal:  Trans N Y Acad Sci       Date:  1966-06
View more
  56 in total

1.  The immunological hazard of Cushing's syndrome.

Authors:  S Britton; M Thorén; H E Sjoberg
Journal:  Br Med J       Date:  1975-12-20

2.  A mission statement for the JCI at the dawn of the 21st century.

Authors:  Andrew R Marks
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Hypopituitarism with water intoxication and coma: favorable outcome following early treatment.

Authors:  R Luboshitzky; J D Sobel; A Kurtzbaum; O S Better; I M Spitz
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

4.  Stability of 125I-labeled staphylococcal enterotoxins in solid-phase radioimmunoassay.

Authors:  P E Kauffman; H M Johnson
Journal:  Appl Microbiol       Date:  1975-06

5.  Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.

Authors:  H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1975-04-15

6.  Plasma beta-endorphin, ACTH and cortisol secretion in man after nasal spray administration of calcitonin.

Authors:  R Franceschini; A Cataldi; T Barreca; M Salvemini; E Rolandi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man.

Authors:  J J Staub; J S Jenkins; J G Ratcliffe; J Landon
Journal:  Br Med J       Date:  1973-02-03

8.  Radioimmunoassay measurement of prostaglandins E2 and F2alpha in human urine.

Authors:  G Ciabattoni; F Pugliese; M Spaldi; G A Cinotti; C Patrono
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

9.  Anticonvulsant therapy and cortisol elimination.

Authors:  P J Evans; R F Walker; J R Peters; J Dyas; D Riad-Fahmy; J P Thomas; E Rimmer; L Tsanaclis; M F Scanlon
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

10.  Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance.

Authors:  C R Cooke; J S Horvath; M A Moore; T Bledsoe; W G Walker
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.